Zobrazeno 1 - 10
of 24
pro vyhledávání: '"James Garvin"'
Autor:
Holly M. Wobma, Prakash Satwani, Larisa Broglie, Diane George, Susana Moscoso, Monica Bhatia, James Garvin, Zhezhen Jin
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:1318-1325
Allogeneic hematopoietic cell transplantation (HCT) has the capacity to cure numerous malignant and nonmalignant disorders. A dreaded complication is graft failure (GF), as it puts patients at high risk of infection and disease relapse. There are few
Autor:
Diane George, Zhezhen Jin, Prakash Satwani, Matthew Hall, James Garvin, Monica Bhatia, Angela Ricci, Sonal Rastogi
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:1253-1259
The literature on the impact of cytomegalovirus (CMV)-related hospitalization in pediatric allogeneic hematopoietic cell transplantation (alloHCT) recipients is limited. The aim of this study was to determine utilization and outcomes of CMV-related h
Autor:
Chalitha Robinson, Esra Karamehmet, Prakash Satwani, Diane George, Michelle Kolb, Andrew L. Kung, Zhezhen Jin, Katharine Offer, James Garvin, Jean Sosna, Monica Bhatia
Publikováno v:
Biology of Blood and Marrow Transplantation. 21(3):496-502
Only a few studies in children have evaluated the efficacy of prophylactic regimens using tacrolimus on acute graft-versus-host disease (aGVHD). As a result, optimal tacrolimus levels in children after matched sibling donor allogeneic hematopoietic c
Autor:
Mark B. Geyer, R. Hawks, M T Lee, Erin Morris, Joseph Schwartz, Prakash Satwani, M Licursi, Mitchell S. Cairo, Courtney Baker, G. Del Toro, Elana Smilow, Warren A. Zuckerman, D. George, Kavita Radhakrishnan, Monica Bhatia, Zhezhen Jin, James Garvin, L.A. Baxter-Lowe
Publikováno v:
Bone Marrow Transplantation. 49:913-920
BU and CY (BU/CY; 200 mg/kg) before HLA-matched sibling allo-SCT in children with sickle cell disease (SCD) is associated with ~85% EFS but is limited by the acute and late effects of BU/CY myeloablative conditioning. Alternatives include reduced tox
Autor:
Diane George, Prakash Satwani, Zhezhen Jin, Leah Violago, Monica Bhatia, James Garvin, Kelly M. Vitale, Jacquelyn Bishop, Paige Cofnas, Andrew L. Kung
Publikováno v:
Pediatric Transplantation. 18:211-216
Palifermin has been demonstrated to decrease the incidence of severe oral mucositis in adults following TBI containing conditioning regimens prior to AHSCT. The impact of palifermin on the incidence of oral mucositis in children undergoing AHSCT has
Autor:
Prakash Satwani, Justine M. Kahn, Andrew L. Kung, Monica Bhatia, Diane George, Grace Yoon-Jeong Kim, Zhezhen Jin, James Garvin, Mahvish Qureshi, Esra Karamehmet, Naima Al Mulla, Anya Levinson
In pediatric and adolescent patients undergoing allogeneic hematopoietic cell transplantation, treatment-related toxicities remain a clinical challenge. A paucity of data investigates the risks for and survival impact of treatment-related toxicities
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f562f0221a389fb8aacfa22df5daee
https://europepmc.org/articles/PMC5496771/
https://europepmc.org/articles/PMC5496771/
Autor:
James Garvin, R. Hawks, Erin Morris, John Le Gall, Carmella van de Ven, Zhezhen Jin, Filemon Dela Cruz, D. George, Sandra Foley, Mitchell S. Cairo, Deirdre Duffy, Prakash Satwani, Lee Ann Baxter-Lowe, Joseph Schwartz, Monica Bhatia
Publikováno v:
Biology of Blood and Marrow Transplantation. 18(2):324-329
Children with high-risk acute myelogenous leukemia (AML) (induction failure [IF], refractory relapse [RR], third complete remission [CR3]) have dismal outcomes. Over 80% of AML patients express CD33, a target of gemtuzumab ozogamicin (GO). GO is an a
Autor:
Lauren Harrison, Judith S. Jacobson, M.B. Bradley, Phyllis Della-Latta, Diane George, Joseph Schwartz, Lee Ann Baxter-Lowe, Jason L. Freedman, Mark B. Geyer, Virginia Moore, Prakash Satwani, Carmella van de Ven, Erin Morris, Monica Bhatia, James Garvin, Mitchell S. Cairo
Publikováno v:
British Journal of Haematology. 155:218-234
Immune reconstitution appears to be delayed following myeloablative conditioning (MAC) and umbilical cord blood transplantation (UCBT) in paediatric recipients. Although reduced toxicity conditioning (RTC) versus MAC prior to allogeneic stem cell tra
Autor:
Mitchell S. Cairo, Joseph E. Schwartz, C. van de Ven, C. Kleinman, M.B. Bradley, Prakash Satwani, James Garvin, D. George, Michelle Neier, Monica Bhatia, Eric S. Silver, Erin Morris, Zhezhen Jin, L. Baldinger
Publikováno v:
Bone Marrow Transplantation. 46:529-538
The objective of this study was to assess the incidence, risk factors, outcome and impact on OS of pericardial effusion (PEF) in a cohort of 156 pediatric SCT recipients. The mean age was 8.15±6.25 years. In all, 74% of the patients had malignant di
Autor:
Prakash Satwani, L.A. Baxter-Lowe, Diane George, B. Tallamy, Monica Bhatia, James Garvin, Michal J. Figurski, Zhezhen Jin, M. Brigid Bradley, Janet Ayello, O. Militano, Erin Morris, Virginia Moore, Leslie M. Shaw, Mitchell S. Cairo, Carmella van deVen
Publikováno v:
Biology of Blood and Marrow Transplantation. 16(3):333-343
Acute graft-versus-host disease (aGVHD) still remains a major limiting factor following allogeneic stem cell transplantation (AlloSCT) in pediatric recipients. Mycophenolate mofetil (MMF), an uncompetitive selective inhibitor of inosine monophosphate